LNCAP in-vitro treatment with androgen receptor targeting drugs
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
Gene expression in LNCaP cells after treatment with the androgen receptor targeting drugs bicalutamide (BIC), enzalutamide (ENZ) and apalutamide (ARN) in the presence or absence of dihydrotestosterone (DHT). Overall design: 16 samples, biological duplicates of LNCaP cells treated with bicalutamide (BIC), enzalutamide (ENZ) or apalutamide (ARN) in the presence or absence of dihydrotestosterone (DHT), respectively.
创建时间：
2025-04-29
